List of Tables
Table 1. Global Inhaled Corticosteroid Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Inhaled Corticosteroid Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Inhaled Corticosteroid Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Inhaled Corticosteroid Covered in This Study
Table 5. Global Inhaled Corticosteroid Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Inhaled Corticosteroid Sales Share by Manufacturers (2016-2021)
Table 7. Global Inhaled Corticosteroid Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Inhaled Corticosteroid Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Inhaled Corticosteroid Average Price (USD/K Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Inhaled Corticosteroid Manufacturing Sites and Area Served
Table 11. Manufacturers Inhaled Corticosteroid Product Type
Table 12. Global Inhaled Corticosteroid Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Inhaled Corticosteroid by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhaled Corticosteroid as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Inhaled Corticosteroid Sales by Region (2016-2021) & (M Units)
Table 16. Global Inhaled Corticosteroid Sales Market Share by Region (2016-2021)
Table 17. Global Inhaled Corticosteroid Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Inhaled Corticosteroid Sales by Country (2016-2021) & (M Units)
Table 19. North America Inhaled Corticosteroid Sales Market Share by Country (2016-2021)
Table 20. North America Inhaled Corticosteroid Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Inhaled Corticosteroid Revenue Market Share by Country (2016-2021)
Table 22. Europe Inhaled Corticosteroid Sales by Country (2016-2021) & (M Units)
Table 23. Europe Inhaled Corticosteroid Sales Market Share by Country (2016-2021)
Table 24. Europe Inhaled Corticosteroid Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Inhaled Corticosteroid Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Inhaled Corticosteroid Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Inhaled Corticosteroid Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Inhaled Corticosteroid Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Inhaled Corticosteroid Revenue Market Share by Region (2016-2021)
Table 30. Latin America Inhaled Corticosteroid Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Inhaled Corticosteroid Sales Market Share by Country (2016-2021)
Table 32. Latin America Inhaled Corticosteroid Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Inhaled Corticosteroid Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Inhaled Corticosteroid Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Inhaled Corticosteroid Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Country (2016-2021)
Table 38. Global Inhaled Corticosteroid Sales (M Units) by Type (2016-2021)
Table 39. Global Inhaled Corticosteroid Sales Market Share by Type (2016-2021)
Table 40. Global Inhaled Corticosteroid Revenue (Million US$) by Type (2016-2021)
Table 41. Global Inhaled Corticosteroid Revenue Share by Type (2016-2021)
Table 42. Global Inhaled Corticosteroid Price (USD/K Unit) by Type (2016-2021)
Table 43. Global Inhaled Corticosteroid Sales (M Units) by Application (2016-2021)
Table 44. Global Inhaled Corticosteroid Sales Market Share by Application (2016-2021)
Table 45. Global Inhaled Corticosteroid Revenue (Million US$) by Application (2016-2021)
Table 46. Global Inhaled Corticosteroid Revenue Share by Application (2016-2021)
Table 47. Global Inhaled Corticosteroid Price (USD/K Unit) by Application (2016-2021)
Table 48. Sumitomo Corporation Information
Table 49. Sumitomo Description and Business Overview
Table 50. Sumitomo Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 51. Sumitomo Inhaled Corticosteroid Product
Table 52. Sumitomo Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 56. Pfizer Inhaled Corticosteroid Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Novartis Corporation Information
Table 59. Novartis Description and Business Overview
Table 60. Novartis Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 61. Novartis Inhaled Corticosteroid Product
Table 62. Novartis Recent Developments/Updates
Table 63. Merck Corporation Information
Table 64. Merck Description and Business Overview
Table 65. Merck Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 66. Merck Inhaled Corticosteroid Product
Table 67. Merck Recent Developments/Updates
Table 68. Sanofi Corporation Information
Table 69. Sanofi Description and Business Overview
Table 70. Sanofi Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 71. Sanofi Inhaled Corticosteroid Product
Table 72. Sanofi Recent Developments/Updates
Table 73. Johnson and Johnson Corporation Information
Table 74. Johnson and Johnson Description and Business Overview
Table 75. Johnson and Johnson Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 76. Johnson and Johnson Inhaled Corticosteroid Product
Table 77. Johnson and Johnson Recent Developments/Updates
Table 78. GSK Corporation Information
Table 79. GSK Description and Business Overview
Table 80. GSK Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 81. GSK Inhaled Corticosteroid Product
Table 82. GSK Recent Developments/Updates
Table 83. AstraZeneca Corporation Information
Table 84. AstraZeneca Description and Business Overview
Table 85. AstraZeneca Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 86. AstraZeneca Inhaled Corticosteroid Product
Table 87. AstraZeneca Recent Developments/Updates
Table 88. Teijin Corporation Information
Table 89. Teijin Description and Business Overview
Table 90. Teijin Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 91. Teijin Inhaled Corticosteroid Product
Table 92. Teijin Recent Developments/Updates
Table 93. Glaxo's Advair Corporation Information
Table 94. Glaxo's Advair Description and Business Overview
Table 95. Glaxo's Advair Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 96. Glaxo's Advair Inhaled Corticosteroid Product
Table 97. Glaxo's Advair Recent Developments/Updates
Table 98. Amgen Corporation Information
Table 99. Amgen Description and Business Overview
Table 100. Amgen Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 101. Amgen Inhaled Corticosteroid Product
Table 102. Amgen Recent Developments/Updates
Table 103. Kos Pharmaceutical Corporation Information
Table 104. Kos Pharmaceutical Description and Business Overview
Table 105. Kos Pharmaceutical Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 106. Kos Pharmaceutical Inhaled Corticosteroid Product
Table 107. Kos Pharmaceutical Recent Developments/Updates
Table 108. Teva Pharmaceutical Corporation Information
Table 109. Teva Pharmaceutical Description and Business Overview
Table 110. Teva Pharmaceutical Inhaled Corticosteroid Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 111. Teva Pharmaceutical Inhaled Corticosteroid Product
Table 112. Teva Pharmaceutical Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Inhaled Corticosteroid Distributors List
Table 116. Inhaled Corticosteroid Customers List
Table 117. Inhaled Corticosteroid Market Trends
Table 118. Inhaled Corticosteroid Growth Drivers
Table 119. Inhaled Corticosteroid Market Restraints
Table 120. Global Inhaled Corticosteroid Sales Forecast by Type (2022-2027) & (M Units)
Table 121. Global Inhaled Corticosteroid Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Inhaled Corticosteroid Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Inhaled Corticosteroid Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Inhaled Corticosteroid Sales Forecast by Application (2022-2027) & (M Units)
Table 125. Global Inhaled Corticosteroid Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Inhaled Corticosteroid Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Inhaled Corticosteroid Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Inhaled Corticosteroid Sales Forecast by Region (2022-2027) & (M Units)
Table 129. Global Inhaled Corticosteroid Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Inhaled Corticosteroid Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Inhaled Corticosteroid Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inhaled Corticosteroid
Figure 2. Global Inhaled Corticosteroid Market Share by Type in 2020 & 2027
Figure 3. Beclomethasone Dipropionate Product Picture
Figure 4. Budesonide Product Picture
Figure 5. Fluticasone Inhaler Powder Product Picture
Figure 6. Mometasone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Inhaled Corticosteroid Market Share by Application in 2020 & 2027
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Respiratory Care Centers
Figure 12. Others
Figure 13. Global Inhaled Corticosteroid Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Inhaled Corticosteroid Market Size 2016-2027 (US$ Million)
Figure 15. Global Inhaled Corticosteroid Sales 2016-2027 (M Units)
Figure 16. Global Inhaled Corticosteroid Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Inhaled Corticosteroid Sales Share by Manufacturers in 2020
Figure 18. Global Inhaled Corticosteroid Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Inhaled Corticosteroid Players: Market Share by Revenue in 2020
Figure 20. Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Inhaled Corticosteroid Sales Market Share by Region (2016-2021)
Figure 22. Global Inhaled Corticosteroid Sales Market Share by Region in 2020
Figure 23. Global Inhaled Corticosteroid Revenue Market Share by Region (2016-2021)
Figure 24. Global Inhaled Corticosteroid Revenue Market Share by Region in 2020
Figure 25. U.S. Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Inhaled Corticosteroid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Inhaled Corticosteroid by Type (2016-2021)
Figure 50. Sales Market Share of Inhaled Corticosteroid by Application (2016-2021)
Figure 51. Sales Market Share of Inhaled Corticosteroid by Application in 2020
Figure 52. Revenue Share of Inhaled Corticosteroid by Application (2016-2021)
Figure 53. Revenue Share of Inhaled Corticosteroid by Application in 2020
Figure 54. Manufacturing Cost Structure of Inhaled Corticosteroid
Figure 55. Manufacturing Process Analysis of Inhaled Corticosteroid
Figure 56. Inhaled Corticosteroid Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

LIST OF FIGURE